Safety and Efficacy of EUS-RFA in Pancreatic Insulinoma

Recruiting now

Conditions studied: Insulinoma; Pancreas

In brief

Transcutaneous and EUS-guided radiofrequency ablation are both modern modalities to apply in the managemnet of various malignancies. In the current study the investigators aim to study the technical feasibility, patient safety and clinical efficacy of EUS-RFA for the treatment of pancreatic insulinoma.

Key facts

Study ID

NCT07585032

Run by

Sahlgrenska University Hospital

People needed

20

Starts

2025-03-31

Expected to finish

2029-06-01

Last updated by the study team

2026-05-13

Who can join

Age: 15 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Insulinoma verified by pathology (often from EUS-FNB-sampling)

You may not qualify if…

• Patients unwilling to participate
• Patients unable to understand and obtain written informed conscent
• Severe comorbidity

Where it is running

• Sahlgrenska Univeristy Hospital — Gothenburg, Sweden (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.